NSE · TCS.NS
Tata Consultancy Services Limited
₹2,521.30+₹43.30 (+1.75%)
Tata Consultancy Services Limited’s quoted price sits in the lower half of its reported 52-week range, 24.74% below the high.
Loading market information…
NSE · TAKE.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
TAKE Solutions Limited’s quoted price sits in the lower half of its reported 52-week range, 78.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
TAKE Solutions Limited’s forward annual dividend is ₹0.80 per share, paid semi-annual. The forward yield is 7.35% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow TAKE Solutions Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
TAKE Solutions Limited, operating across the United States, Asia Pacific, and Europe, specializes in providing expert services and cutting-edge solutions for the life sciences and supply chain management sectors. For the life sciences industry, the company delivers technology-driven and proprietary solutions, alongside consulting and practical services covering clinical trials, regulatory compliance, and patient safety. Its specific offerings in this area include clinical research, development of generic drugs, data analytics, regulatory affairs management, and pharmacovigilance. Beyond this, TAKE Solutions also offers IT infrastructure and support, comprehensive supply chain management, engineering, design, and sourcing services. The company caters to a diverse client base, encompassing both major and smaller innovative biopharmaceutical and medical device firms, as well as generic drug producers. Established in 2000, its main office is located in Chennai, India. TAKE Solutions Limited functions as a subsidiary of TAKE Solutions Pte. Limited.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹2,521.30+₹43.30 (+1.75%)
Tata Consultancy Services Limited’s quoted price sits in the lower half of its reported 52-week range, 24.74% below the high.
₹136.00-₹0.54 (-0.4%)
ZIM Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.9% below the high.
₹418.35-₹11.80 (-2.74%)
Trident Lifeline Limited’s quoted price sits in the upper half of its reported 52-week range, 4.46% below the high.
₹1,382.00-₹47.20 (-3.3%)
Haleos Labs Limited’s quoted price sits in the lower half of its reported 52-week range, 22.1% below the high.
₹1,299.00+₹10.50 (+0.81%)
SMS Lifesciences India Limited’s quoted price sits in the lower half of its reported 52-week range, 22.68% below the high.
₹77.00+₹0.75 (+0.98%)
Lyka Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 21.63% below the high.
₹10.18-₹0.15 (-1.45%)
Nectar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 54.55% below the high.
₹62.16-₹1.68 (-2.63%)
Brooks Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 46.41% below the high.
